Pharma & Healthcare

Global Ophthalmic AAV Gene Therapy Market Research Report 2026

This report delivers a comprehensive overview of the global Ophthalmic AAV Gene Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ophthalmic AAV Gene Therapy. The Ophthalmic AAV Gene Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ophthalmic AAV Gene Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ophthalmic AAV Gene Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Spark/Roche (Luxturna)
GenSight Biologics (Pipeline)
Segment by Type
Subretinal Injection
Intravitreous Injection
Segment by Application
Retinopathy
Optic Atrophy
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Ophthalmic AAV Gene Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic AAV Gene Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Subretinal Injection
1.2.3 Intravitreous Injection
1.3 Market by Application
1.3.1 Global Ophthalmic AAV Gene Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Retinopathy
1.3.3 Optic Atrophy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic AAV Gene Therapy Market Perspective (2021–2032)
2.2 Global Ophthalmic AAV Gene Therapy Growth Trends by Region
2.2.1 Global Ophthalmic AAV Gene Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Ophthalmic AAV Gene Therapy Historic Market Size by Region (2021–2026)
2.2.3 Ophthalmic AAV Gene Therapy Forecasted Market Size by Region (2027–2032)
2.3 Ophthalmic AAV Gene Therapy Market Dynamics
2.3.1 Ophthalmic AAV Gene Therapy Industry Trends
2.3.2 Ophthalmic AAV Gene Therapy Market Drivers
2.3.3 Ophthalmic AAV Gene Therapy Market Challenges
2.3.4 Ophthalmic AAV Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ophthalmic AAV Gene Therapy Players by Revenue
3.1.1 Global Top Ophthalmic AAV Gene Therapy Players by Revenue (2021–2026)
3.1.2 Global Ophthalmic AAV Gene Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Ophthalmic AAV Gene Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Ophthalmic AAV Gene Therapy Revenue
3.4 Global Ophthalmic AAV Gene Therapy Market Concentration Ratio
3.4.1 Global Ophthalmic AAV Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic AAV Gene Therapy Revenue in 2025
3.5 Global Key Players of Ophthalmic AAV Gene Therapy Head Offices and Areas Served
3.6 Global Key Players of Ophthalmic AAV Gene Therapy, Products and Applications
3.7 Global Key Players of Ophthalmic AAV Gene Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Ophthalmic AAV Gene Therapy Breakdown Data by Type
4.1 Global Ophthalmic AAV Gene Therapy Historic Market Size by Type (2021–2026)
4.2 Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Type (2027–2032)
5 Ophthalmic AAV Gene Therapy Breakdown Data by Application
5.1 Global Ophthalmic AAV Gene Therapy Historic Market Size by Application (2021–2026)
5.2 Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Ophthalmic AAV Gene Therapy Market Size (2021–2032)
6.2 North America Ophthalmic AAV Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Ophthalmic AAV Gene Therapy Market Size by Country (2021–2026)
6.4 North America Ophthalmic AAV Gene Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ophthalmic AAV Gene Therapy Market Size (2021–2032)
7.2 Europe Ophthalmic AAV Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Ophthalmic AAV Gene Therapy Market Size by Country (2021–2026)
7.4 Europe Ophthalmic AAV Gene Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size (2021–2032)
8.2 Asia-Pacific Ophthalmic AAV Gene Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Ophthalmic AAV Gene Therapy Market Size (2021–2032)
9.2 Latin America Ophthalmic AAV Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Ophthalmic AAV Gene Therapy Market Size by Country (2021–2026)
9.4 Latin America Ophthalmic AAV Gene Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size (2021–2032)
10.2 Middle East & Africa Ophthalmic AAV Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Spark/Roche (Luxturna)
11.1.1 Spark/Roche (Luxturna) Company Details
11.1.2 Spark/Roche (Luxturna) Business Overview
11.1.3 Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Introduction
11.1.4 Spark/Roche (Luxturna) Revenue in Ophthalmic AAV Gene Therapy Business (2021–2026)
11.1.5 Spark/Roche (Luxturna) Recent Development
11.2 GenSight Biologics (Pipeline)
11.2.1 GenSight Biologics (Pipeline) Company Details
11.2.2 GenSight Biologics (Pipeline) Business Overview
11.2.3 GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Introduction
11.2.4 GenSight Biologics (Pipeline) Revenue in Ophthalmic AAV Gene Therapy Business (2021–2026)
11.2.5 GenSight Biologics (Pipeline) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Ophthalmic AAV Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Subretinal Injection
Table 3. Key Players of Intravitreous Injection
Table 4. Global Ophthalmic AAV Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Ophthalmic AAV Gene Therapy Market Share by Region (2021–2026)
Table 8. Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Ophthalmic AAV Gene Therapy Market Share by Region (2027–2032)
Table 10. Ophthalmic AAV Gene Therapy Market Trends
Table 11. Ophthalmic AAV Gene Therapy Market Drivers
Table 12. Ophthalmic AAV Gene Therapy Market Challenges
Table 13. Ophthalmic AAV Gene Therapy Market Restraints
Table 14. Global Ophthalmic AAV Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Ophthalmic AAV Gene Therapy Market Share by Players (2021–2026)
Table 16. Global Top Ophthalmic AAV Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ophthalmic AAV Gene Therapy Revenue, 2025
Table 17. Ranking of Global Top Ophthalmic AAV Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Ophthalmic AAV Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Ophthalmic AAV Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Ophthalmic AAV Gene Therapy, Products and Applications
Table 21. Global Key Players of Ophthalmic AAV Gene Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Ophthalmic AAV Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Ophthalmic AAV Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Ophthalmic AAV Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Ophthalmic AAV Gene Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Spark/Roche (Luxturna) Company Details
Table 47. Spark/Roche (Luxturna) Business Overview
Table 48. Spark/Roche (Luxturna) Ophthalmic AAV Gene Therapy Product
Table 49. Spark/Roche (Luxturna) Revenue in Ophthalmic AAV Gene Therapy Business (US$ Million), 2021–2026
Table 50. Spark/Roche (Luxturna) Recent Development
Table 51. GenSight Biologics (Pipeline) Company Details
Table 52. GenSight Biologics (Pipeline) Business Overview
Table 53. GenSight Biologics (Pipeline) Ophthalmic AAV Gene Therapy Product
Table 54. GenSight Biologics (Pipeline) Revenue in Ophthalmic AAV Gene Therapy Business (US$ Million), 2021–2026
Table 55. GenSight Biologics (Pipeline) Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
Table 59. Authors List of This Report


List of Figures
Figure 1. Ophthalmic AAV Gene Therapy Picture
Figure 2. Global Ophthalmic AAV Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Ophthalmic AAV Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. Subretinal Injection Features
Figure 5. Intravitreous Injection Features
Figure 6. Global Ophthalmic AAV Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Ophthalmic AAV Gene Therapy Market Share by Application: 2025 vs 2032
Figure 8. Retinopathy Case Studies
Figure 9. Optic Atrophy Case Studies
Figure 10. Ophthalmic AAV Gene Therapy Report Years Considered
Figure 11. Global Ophthalmic AAV Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Ophthalmic AAV Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Ophthalmic AAV Gene Therapy Market Share by Region: 2025 vs 2032
Figure 14. Global Ophthalmic AAV Gene Therapy Market Share by Players in 2025
Figure 15. Global Ophthalmic AAV Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Ophthalmic AAV Gene Therapy Revenue in 2025
Figure 17. North America Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 19. United States Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 23. Germany Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Ophthalmic AAV Gene Therapy Market Share by Region (2021–2032)
Figure 31. China Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 39. Mexico Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Ophthalmic AAV Gene Therapy Market Share by Country (2021–2032)
Figure 43. Israel Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Ophthalmic AAV Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Spark/Roche (Luxturna) Revenue Growth Rate in Ophthalmic AAV Gene Therapy Business (2021–2026)
Figure 47. GenSight Biologics (Pipeline) Revenue Growth Rate in Ophthalmic AAV Gene Therapy Business (2021–2026)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies